Kyverna Therapeutics, Inc. (KYTX) ownership: Top institutional holder: GordonMD Global Investments LP ($36.63M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| GordonMD Global Investments LP | 4244818.00 | $36.63M | 2026-03-31 |
| GILEAD SCIENCES, INC. | 4126119.00 | $35.61M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | 3110000.00 | $26.84M | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2000000.00 | $17.26M | 2026-03-31 |
| AIGH Capital Management LLC | 2000000.00 | $17.26M | 2026-03-31 |
| VANGUARD GROUP INC | 1781257.00 | $16.74M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1783342.00 | $15.39M | 2026-03-31 |
| Balyasny Asset Management L.P. | 1125321.00 | $9.71M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 |
Back to KYTX overview · KYTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.